The epidemic history of hepatitis C among injecting drug users in Flanders, Belgium
Article first published online: 30 JAN 2008
DOI: 10.1111/j.1365-2893.2007.00950.x
© 2008 The Authors. Journal compilation © 2008 Blackwell Publishing Ltd
Additional Information
How to Cite
Matheï, C., Van Dooren, S., Lemey, P., Van Damme, P., Buntinx, F. and Vandamme, A.-M. (2008), The epidemic history of hepatitis C among injecting drug users in Flanders, Belgium. Journal of Viral Hepatitis, 15: 399–408. doi: 10.1111/j.1365-2893.2007.00950.x
Publication History
- Issue published online: 30 JAN 2008
- Article first published online: 30 JAN 2008
- Received August 2007; accepted for publication October 2007
- Abstract
- Article
- References
- Cited By
Summary. We employed recently developed statistical methods to explore the epidemic behaviour of hepatitis C subtype 1a and subtype 3a among injecting drug users (IDUs) in Flanders, Belgium, using new gene sequence data sampled among two geographically distinct populations of IDUs. First the extent of hepatitis C transmission across regions/countries was studied through calculation of association indices. It was shown that viral exchange had occurred between both populations in Flanders as well as across international borders. Furthermore, evidence was found suggestive of subtypes 1a and 3a predominantly circulating in subpopulations of Flemish IDUs, exhibiting different degrees of travelling/migration behaviour. Secondly, through coalescent-based analysis the viral epidemic history of the hepatitis C subtype 1a and 3a epidemics was inferred. Evidence was found for different dynamic forces driving both epidemics. Moreover, results suggested that the hepatitis C subtype 3a epidemic has reached a steady state, while the hepatitis C 1a epidemic has not, which therefore might become the predominant subtype among IDUs.

1365-2893/asset/JVH_left.gif?v=1&s=b49347dbb27ed46f9f14bd61c3304105cb5a53be)
